Q1 2023 Earnings Estimate for CME Group Inc. Issued By Oppenheimer (NASDAQ:CME)

CME Group Inc. (NASDAQ:CMEGet Rating) – Research analysts at Oppenheimer reduced their Q1 2023 earnings per share estimates for shares of CME Group in a report released on Wednesday, January 18th. Oppenheimer analyst O. Lau now anticipates that the financial services provider will post earnings per share of $2.09 for the quarter, down from their prior forecast of $2.13. Oppenheimer currently has a “Outperform” rating and a $213.00 target price on the stock. The consensus estimate for CME Group’s current full-year earnings is $7.94 per share. Oppenheimer also issued estimates for CME Group’s Q2 2023 earnings at $2.04 EPS, Q3 2023 earnings at $2.05 EPS, Q4 2023 earnings at $1.99 EPS, FY2023 earnings at $8.18 EPS and FY2024 earnings at $8.52 EPS.

Other equities analysts have also issued reports about the stock. Rosenblatt Securities dropped their price target on shares of CME Group from $171.00 to $161.00 and set a “sell” rating for the company in a research report on Wednesday, October 5th. Credit Suisse Group raised CME Group from a “neutral” rating to an “outperform” rating and set a $191.00 price target on the stock in a report on Thursday, January 5th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of CME Group from $207.00 to $200.00 in a report on Wednesday, January 11th. UBS Group lowered their target price on shares of CME Group from $226.00 to $220.00 in a report on Thursday, January 5th. Finally, Morgan Stanley cut their target price on shares of CME Group from $208.00 to $196.00 and set an “equal weight” rating for the company in a research note on Wednesday, January 11th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $220.73.

CME Group Stock Up 0.5 %

Shares of CME stock opened at $175.06 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group has a 12 month low of $166.54 and a 12 month high of $256.94. The stock has a market cap of $62.97 billion, a P/E ratio of 23.82, a P/E/G ratio of 3.54 and a beta of 0.40. The company has a 50 day simple moving average of $174.21 and a two-hundred day simple moving average of $184.35.

CME Group (NASDAQ:CMEGet Rating) last released its quarterly earnings results on Wednesday, October 26th. The financial services provider reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.05. CME Group had a return on equity of 10.06% and a net margin of 54.01%. The business had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.23 billion.

Institutional Investors Weigh In On CME Group

Several large investors have recently modified their holdings of the business. Heritage Financial Services LLC purchased a new position in CME Group during the second quarter valued at approximately $25,000. J.W. Cole Advisors Inc. purchased a new position in shares of CME Group in the 1st quarter valued at $26,000. Power Corp of Canada bought a new position in shares of CME Group in the 1st quarter worth $26,000. EWG Elevate Inc. purchased a new position in CME Group in the fourth quarter valued at about $27,000. Finally, Arlington Partners LLC bought a new position in CME Group in the fourth quarter worth about $27,000. Institutional investors own 85.09% of the company’s stock.

Insider Buying and Selling at CME Group

In related news, Director William R. Shepard bought 48,645 shares of the stock in a transaction dated Friday, November 4th. The stock was purchased at an average cost of $170.00 per share, with a total value of $8,269,650.00. Following the completion of the purchase, the director now owns 247,843 shares of the company’s stock, valued at $42,133,310. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.30% of the stock is currently owned by corporate insiders.

CME Group Increases Dividend

The firm also recently disclosed a None dividend, which was paid on Wednesday, January 18th. Investors of record on Wednesday, December 28th were issued a dividend of $4.50 per share. The ex-dividend date was Tuesday, December 27th. This is a boost from CME Group’s previous None dividend of $3.25. CME Group’s payout ratio is presently 54.42%.

CME Group Company Profile

(Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

Featured Stories

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.